FTSE upbeat this morning

clock

Man Group has got off to a flyer this morning helping the FTSE 100 benchmark to an early gain of about 15 points to 4,599 points.

Man is trading up 25p at 1,302p. Shire Pharmaceuticals is up 19p to 540.75p. The U.K.'s third-largest drugmaker said the US Food and Drug Administration approved its Fosrenol treatment for kidney-failure patients with estimated sales of $200m. Companies performing poorly include British Sky Broadcasting, down 4.25p to 491.25p. Centrica is down 2.25p to 236p. Japanese stocks rose earlier this morning, led by financial companies including Resona and Shinsei Bank after report first-half profits were ahead of forecasts. Tokyo's Nikkei 225 index added 0.2% to 10,691.95 points. Orix...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Advisers expecting more of asset managers since Consumer Duty

Advisers expecting more of asset managers since Consumer Duty

‘We actually need to understand one another better’

Hope Coumbe
clock 28 March 2024 • 1 min read
Fears tech limitations could stall MPS on its upward trajectory

Fears tech limitations could stall MPS on its upward trajectory

‘There have been a few changes and challenges around growth in general’

Hope Coumbe
clock 27 March 2024 • 1 min read
Partner Insight: Beyond 60/40

Partner Insight: Beyond 60/40

Invesco
clock 27 March 2024 • 5 min read